<code id='F31754EFB9'></code><style id='F31754EFB9'></style>
    • <acronym id='F31754EFB9'></acronym>
      <center id='F31754EFB9'><center id='F31754EFB9'><tfoot id='F31754EFB9'></tfoot></center><abbr id='F31754EFB9'><dir id='F31754EFB9'><tfoot id='F31754EFB9'></tfoot><noframes id='F31754EFB9'>

    • <optgroup id='F31754EFB9'><strike id='F31754EFB9'><sup id='F31754EFB9'></sup></strike><code id='F31754EFB9'></code></optgroup>
        1. <b id='F31754EFB9'><label id='F31754EFB9'><select id='F31754EFB9'><dt id='F31754EFB9'><span id='F31754EFB9'></span></dt></select></label></b><u id='F31754EFB9'></u>
          <i id='F31754EFB9'><strike id='F31754EFB9'><tt id='F31754EFB9'><pre id='F31754EFB9'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:919
          Richard Gonzalez
          Abbvie CEO Richard Gonzalez will step down in July. Jacquelyn Martin/AP

          AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in 2013, will step down in July. Gonzalez had previously said he would depart when AbbVie had a plan in place to move on from its best-selling drug, Humira, which is now facing competition from cheaper biosimilars.

          He will be replaced by Chief Operating Officer Robert Michael, who, like Gonzalez, is a longtime AbbVie executive. Gonzalez, 70, will become executive chairman of the board of directors.

          advertisement

          Gonzalez should be a sobering reminder to the drug industry’s critics of how resilient a CEO’s reputation can be. Because while he has been a subject of nearly constant criticism for AbbVie’s handling of Humira and the patents protecting it, investors are likely to remember him fondly.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire
          Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

          2:34FormerVicepresidentMikePencespeakswithguestsduringacampaignstophemadewithhiswifeKaren,July6,2023

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

          2:13FILE-TheburnedremainsofahomedestroyedbytheMarshallFireareshown,Jan.7,2022,inLouisville,Colo.OnTh